Sergio Trujillo-Lopez

Dr. Sergio Trujillo-Lopez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MHMaría Elena Ochoa Hernández
María Elena Ochoa Hernández
LLLidianys María Lewis Luján
Lidianys María Lewis Luján
MZMaría Guadalupe Burboa Zazueta
María Guadalupe Burboa Zazueta
TCTERESA DEL CASTILLO
TERESA DEL CASTILLO
EVEnrique De la Re Vega
Enrique De la Re Vega
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga
Age-related macular degeneration (AMD) is a leading cause of visual impairment worldwide, characterized by the accumulation of extracellular drusen deposits within the macula. The pathogenesis of AMD is multifactorial, involving oxidative stress, chronic inflammation, immune system dysregulation, and genetic predisposition. A key contributor to disease progression is the excessive accumulation of reactive oxygen species (ROS), which damage retinal pigment epithelium (RPE) cells and disrupt cellular homeostasis. Additionally, immunosenescence and chronic low-grade inflammation exacerbate AMD pathology, further impairing retinal integrity. Despite ongoing research, effective therapeutic options remain limited, and there is no definitive cure for AMD. This review explores the intricate molecular mechanisms underlying AMD, including the role of oxidative stress, chronic inflammation, and genetic factors in RPE dysfunction. Furthermore, we highlight potential therapeutic strategies targeting these pathways, as well as the emerging role of bioinformatics and artificial intelligence in AMD diagnosis and treatment development. By improving our understanding of AMD pathophysiology, we can advance the search for novel therapeutic interventions and preventative strategies.

10 August 2025 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
LLLidianys María Lewis Luján
Lidianys María Lewis Luján
CMCinthiaJhovanna Perez Martinez
CinthiaJhovanna Perez Martinez
AIAnnette Pulcherie Iloki‐Lewis
Annette Pulcherie Iloki‐Lewis
DGDiego Emmanuel Guerrero-Magaña
Diego Emmanuel Guerrero-Magaña
JDJudas Tadeo Vargas Durazo
Judas Tadeo Vargas Durazo
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga

11 July 2024 in Human Nutrition & Metabolism
Verified
Journal Article
Open access
LLLidianys María Lewis Luján
Lidianys María Lewis Luján
MMark Mccarty
Mark Mccarty
JRJuan Carlos Galvez Ruiz
Juan Carlos Galvez Ruiz
STSergio Trujillo-Lopez
Sergio Trujillo-Lopez
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga
Non-alcoholic fatty liver disease (NAFLD), a frequent complication of metabolic syndrome and visceral obesity, is characterized by marked accumulation of lipids in hepatocytes, accompanied by oxidant stress. In a substantial minority of cases, this progresses to steatohepatitis, which in turn can lead to life-threatening hepatic fibrosis and/or hepatocarcinogenesis . This essay analyzes the molecular biology underlying fat accumulation and oxidant stress in NAFLD and identifies targets that can be addressed by nutraceutical or dietary measures. Nutraceuticals with potential for prevention or control of NAFLD as suggested on theoretical grounds, and borne out by experience in rodent studies and/or clinical trials include ferulic acid , melatonin, methyl nicotinamide , tetrahydro curcumin , nicotinamide riboside, carnosic acid , urolithin A, quercetin, high-dose biotin , citrulline, astaxanthin , long-chain omega-3 fatty acids, berberine, lipoic acid , silibinin, N-acetylcysteine, taurine, capsaicin, spermidine, spirulina , and carnitine. Some of these agents can also address the NLRP3 inflammasome activation and transforming growth factor-β signaling that play a role in driving the transition to steatohepatitis and fibrosis. In addition, soy isoflavones, via estrogen receptor-beta agonism, have anti-fibrotic potential, and supplemental glycine may blunt the contribution of Kupffer cells to the progression of NAFLD. Methods: The research articles to carry out this work were focused based on many searches and reviews in the following databases: Google Scholar, MDPI, PubMed , ScienceDirect and using the following keywords and combined synonyms: ("nutraceuticals" or " dietary measures " or " Non-alcoholic fatty liver disease (NAFLD) " or "Nrf2″ or "Vegan diet”) AND (“NAFLD” or “vascular function” or “inflammation”). The keywords were also searched in the references of the original articles included in this study Whole-food plant-based diets of modest protein content, owing to their impact on hormones such as fibroblast growth factor 21 and adiponectin , as well as on the obesity and metabolic syndrome underlying NAFLD, may also be protective in this syndrome. There is considerable potential for complex medical foods or nutraceutical supplementation regimens of rational design to aid prevention and control of NAFLD.

1 January 2022 in Revista Latinoamericana de Simulación Clínica
Verified
Journal Article
Closed access
PDF file
GGGilberto Gastélum-Hernández
Gilberto Gastélum-Hernández
JMJuan Antonio Medina-Aguirre
Juan Antonio Medina-Aguirre
STSergio Trujillo-Lopez
Sergio Trujillo-Lopez
APAziel Alejandro Peralta-Ramírez
Aziel Alejandro Peralta-Ramírez

13 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LLLidianys María Lewis Luján
Lidianys María Lewis Luján
MHMaría Elena Ochoa Hernandez
María Elena Ochoa Hernandez
JGJuan-Carlos Galvez-Ruiz
Juan-Carlos Galvez-Ruiz
NANesty Olivares Arzuaga
Nesty Olivares Arzuaga
MBMaría Guadalupe Burboa-Zazueta
María Guadalupe Burboa-Zazueta
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga
The major cause for blindness worldwide is age-related macular degeneration (AMD), and its incidence and prevalence are rising. There is no treatment for the early or atrophic forms of AMD. In terms of pathogenesis, the complex interaction of metabolic, functional, genetic, and environmental factors creates a stage for chronically developing changes in ocular structures of the macular region which contribute to varying degrees to the onset and final picture of AMD. Oxidative stress is a constant condition of the retina. Brown seaweed contains bioactive compounds with promising activities that make them interesting for potential use in AMD, such as the polysaccharide fucoidan, the carotenoid fucoxanthin and fucoxanthinol. Considering fucoidans, their heterogeneity requires intensive research to find suitable fucoidans for further applications. Fucoxanthin and its metabolite, fucoxanthinol, have shown antioxidant activities attributed to free radical scavenging and singlet oxygen inactivation in vitro. Fucoxanthin has greater antioxidant activity and is considered a potential protective agent against oxidative stress. This review gives an overview of the recent studies regarding their potential and challenges.

Verified
Journal Article
Open access
PDF file
LLLidianys María Lewis Luján
Lidianys María Lewis Luján
AIAnnette Pulcherie Iloki-Lewis
Annette Pulcherie Iloki-Lewis
DGDiego Emmanuel Guerrero-Magaña
Diego Emmanuel Guerrero-Magaña
MOMikhail A. Osadchuk
Mikhail A. Osadchuk
MTMaxim V. Trushin
Maxim V. Trushin
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga
Plant-derived bioactive metabolites have emerged as promising modulators of oxidative stress and inflammation, two interconnected processes involved in the pathogenesis of numerous chronic diseases. Arid ecosystems, particularly the Sonoran Desert, constitute an underexplored source of structurally diverse phytochemicals with significant pharmacological potential. This review provides a comprehensive overview of major classes of plant-derived bioactives, including polyphenols, flavonoids, terpenoids, and alkaloids, with emphasis on their molecular mechanisms of antioxidant and anti-inflammatory action. These compounds exert cytoprotective effects through direct reactive oxygen species (ROS) scavenging and indirect regulation of endogenous defense systems, primarily via activation of the Nrf2/Keap1 pathway and suppression of NF-κB signaling. Additional pathways, including MAPK, PI3K/Akt, AMPK, and mitochondrial regulatory networks, are discussed as critical mediators of redox balance and inflammatory control. Particular attention is given to Sonoran Desert plant species such as Bucida buceras, Phoradendron californicum, Larrea tridentata, Opuntia spp., and Agave deserti, all of which demonstrate promising biological activities associated with enhanced adaptation to environmental stress. Experimental approaches used to evaluate phytochemical bioactivity, including chemical assays, cellular models, omics technologies, and translational strategies, are also examined. Furthermore, this review discusses current limitations related to bioavailability, phytochemical variability, and clinical validation, highlighting emerging nanodelivery systems and precision medicine approaches as potential solutions. Collectively, the evidence supports the therapeutic relevance of Sonoran Desert plant bioactives as multi-target agents for modulating oxidative stress, inflammation, and chronic disease progression.